Kintegral Advisory’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.9M | Hold |
91,933
| – | – | 0.96% | 25 |
|
|
2026
Q1 | $11.1M | Sell |
91,933
-4,076
| -4% | -$471K | 1.06% | 19 |
|
|
2025
Q4 | $10.2M | Sell |
96,009
-2,627
| -3% | -$247K | 0.86% | 22 |
|
|
2025
Q3 | $8.36M | Sell |
98,636
-441
| -0.4% | -$36.3K | 0.71% | 27 |
|
|
2025
Q2 | $7.92M | Sell |
99,077
-149
| -0.2% | -$11.8K | 0.72% | 29 |
|
|
2025
Q1 | $8.99M | Sell |
99,226
-334
| -0.3% | -$31.2K | 0.91% | 23 |
|
|
2024
Q4 | $9.99M | Sell |
99,560
-4,638
| -4% | -$478K | 0.94% | 21 |
|
|
2024
Q3 | $11.9M | Sell |
104,198
-1,365
| -1% | -$162K | 1.09% | 13 |
|
|
2024
Q2 | $13.1M | Buy |
105,563
+14,921
| +16% | +$1.92M | 1.26% | 9 |
|
|
2024
Q1 | $12M | Sell |
90,642
-283
| -0.3% | -$34.9K | 1.2% | 14 |
|
|
2023
Q4 | $9.98M | Sell |
90,925
-579
| -0.6% | -$60.1K | 1.11% | 14 |
|
|
2023
Q3 | $9.49M | Sell |
91,504
-54
| -0.1% | -$5.82K | 1.17% | 13 |
|
|
2023
Q2 | $10.6M | Hold |
91,558
| – | – | 1.26% | 11 |
|
|
2023
Q1 | $9.81M | Sell |
91,558
-4,919
| -5% | -$531K | 1.27% | 11 |
|
|
2022
Q4 | $10.8M | Sell |
96,477
-11,352
| -11% | -$1.16M | 1.42% | 7 |
|
|
2022
Q3 | $9.36M | Hold |
107,829
| – | – | 1.3% | 10 |
|
|
2022
Q2 | $9.9M | Buy |
107,829
+2,283
| +2% | +$202K | 1.29% | 11 |
|
|
2022
Q1 | $8.73M | Buy |
105,546
+2,360
| +2% | +$186K | 0.96% | 18 |
|
|
2021
Q4 | $7.98M | Hold |
103,186
| – | – | 0.83% | 23 |
|
|
2021
Q3 | $7.82M | Hold |
103,186
| – | – | 0.92% | 22 |
|
|
2021
Q2 | $8.09M | Sell |
103,186
-4,953
| -5% | -$368K | 0.96% | 21 |
|
|
2021
Q1 | $8.09M | Hold |
108,139
| – | – | 1.04% | 18 |
|
|
2020
Q4 | $8.51M | Hold |
108,139
| – | – | 1.15% | 16 |
|
|
2020
Q3 | $8.62M | Sell |
108,139
-3,480
| -3% | -$273K | 1.31% | 13 |
|
|
2020
Q2 | $8.3M | Hold |
111,619
| – | – | 1.34% | 11 |
|
|
2020
Q1 | $8.26M | Buy |
111,619
+12,489
| +13% | +$982K | 1.61% | 10 |
|
|
2019
Q4 | $8.66M | Hold |
99,130
| – | – | 1.57% | 10 |
|
|
2019
Q3 | $8.02M | Hold |
99,130
| – | – | 1.6% | 10 |
|
|
2019
Q2 | $7.98M | Hold |
99,130
| – | – | 1.62% | 10 |
|
|
2019
Q1 | $7.87M | Sell |
99,130
-3,997
| -4% | -$299K | 1.66% | 11 |
|
|
2018
Q4 | $7.57M | Buy |
+103,127
| New | +$7.28M | 2.24% | 8 |
|
Other funds holding MRK
Kintegral Advisory's MRK Position: Q2 2026 in Review
Kintegral Advisory held its Merck (MRK) position steady in Q2 2026 at 91,933 shares worth $11.9M. The position accounts for 0.96% of the portfolio, ranked #25.
Kintegral Advisory first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $13.1M in Q2 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Kintegral Advisory held 91,933 shares of Merck worth $11.9M as of Q2 2026.
- Kintegral Advisory left its Merck share count unchanged in Q2 2026.
- Merck made up 0.96% of Kintegral Advisory's portfolio in Q2 2026, its #25 holding.
- Kintegral Advisory first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- Kintegral Advisory's Merck position peaked at $13.1M in Q2 2024.
- 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Kintegral Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.